ConductScience.org, home

Paper36747244

Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.

Chiarito M and 16 others. Cardiovasc Diabetol, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial. Papers, record 36747244. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36747244

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Safety of metformin continuation in diabetic patients undergoing invasive coronary angiography: the NO-STOP single arm trial.
PubMed
Journal
Cardiovasc Diabetol
PubMed
Year
2023
PubMed
Publication types
Clinical Trial, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.17
iCite
Revised in PubMed
2023-02-13
PubMed

Authors17

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Chiarito MMauro
2Sanz-Sanchez JJorge
3Piccolo RRaffaele
4Condello FFrancesco
5Liccardo GGaetano
6Maurina MMatteo
7Avvedimento MMarisa
8Regazzoli DDamiano
9Pagnotta PPaolo
10Garcia-Garcia HMHector M
11Mehran RRoxana
12Federici MMassimo
13Condorelli GGianluigi
14Diez Gil JLJose Luis
15Reimers BBernhard
16Ferrante GGiuseppe
17Stefanini GGiulio

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Acidosis, LacticMajor topic
Acute Kidney InjuryMajor topic
Diabetes MellitusMajor topic
MetforminMajor topic
Humans
Coronary Angiography
Hypoglycemic Agents
Lactates
Prospective Studies

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04766008Metformin in Diabetic Patients Undergoing Coronary AngiographyDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References30

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1306673612018 ESC/EACTS Guidelines on myocardial revascularization.EuroIntervention2019https://conductscience.org/library/papers/30667361PubMed
222965137Periprocedural management of the patient with diabetes mellitus undergoing coronary angiography: current practice.Arch Intern Med2012https://conductscience.org/library/papers/22965137PubMed
318945920
Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes.
Diabetes Care2009https://conductscience.org/library/papers/18945920PubMed
410359389
Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
JAMA1999https://conductscience.org/library/papers/10359389PubMed
530165617Fourth universal definition of myocardial infarction (2018).Eur Heart J2019https://conductscience.org/library/papers/30165617PubMed
625317875The target of metformin in type 2 diabetes.N Engl J Med2014https://conductscience.org/library/papers/25317875PubMed
720338463Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.Am J Kidney Dis2010https://conductscience.org/library/papers/20338463PubMed
834895951
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.
J Am Coll Cardiol2022https://conductscience.org/library/papers/34895951PubMed
927656713Effect of Metformin on Renal Function After Primary Percutaneous Coronary Intervention in Patients Without Diabetes Presenting with ST-elevation Myocardial Infarction: Data from the GIPS-III Trial.Cardiovasc Drugs Ther2015https://conductscience.org/library/papers/27656713PubMed
1019414839A new equation to estimate glomerular filtration rate.Ann Intern Med2009https://conductscience.org/library/papers/19414839PubMed
1134187171Evidence-Based Practices in the Cardiac Catheterization Laboratory: A Scientific Statement From the American Heart Association.Circulation2021https://conductscience.org/library/papers/34187171PubMed
1221851878Renal function-based contrast dosing to define safe limits of radiographic contrast media in patients undergoing percutaneous coronary interventions.J Am Coll Cardiol2011https://conductscience.org/library/papers/21851878PubMed
1326773926Metformin-associated lactic acidosis: Current perspectives on causes and risk.Metabolism2016https://conductscience.org/library/papers/26773926PubMed
1424630791Periprocedural glycemic control in patients with diabetes mellitus undergoing coronary angiography with possible percutaneous coronary intervention.Am J Cardiol2014https://conductscience.org/library/papers/24630791PubMed
1520032157Systematic review of current guidelines, and their evidence base, on risk of lactic acidosis after administration of contrast medium for patients receiving metformin.Radiology2010https://conductscience.org/library/papers/20032157PubMed
1615464318A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.J Am Coll Cardiol2004https://conductscience.org/library/papers/15464318PubMed
1732316910Effect of continuous use of metformin on kidney function in diabetes patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.BMC Cardiovasc Disord2020https://conductscience.org/library/papers/32316910PubMed
1835058000Randomized Comparison of Metformin Continuation Versus Interruption Following Coronary Angiography/Angioplasty: Contemporary Risk for Lactic Acidosis.JACC Cardiovasc Interv2022https://conductscience.org/library/papers/35058000PubMed
1927060269One-year clinical outcome of amphilimus polymer-free drug-eluting stent in diabetes mellitus patients: Insight from the ASTUTE registry (AmphilimuS iTalian mUlticenTre rEgistry).Int J Cardiol2016https://conductscience.org/library/papers/27060269PubMed
2029417249
Post-contrast acute kidney injury. Part 2: risk stratification, role of hydration and other prophylactic measures, patients taking metformin and chronic dialysis patients : Recommendations for updated ESUR Contrast Medium Safety Committee guidelines.
Eur Radiol2018https://conductscience.org/library/papers/29417249PubMed

See all 30 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
41213823Left main percutaneous or surgical revascularisation and subsequent risk of transient and persistent renal dysfunction.Open Heart2025https://conductscience.org/library/papers/41213823PubMed
39786492Beneficial effects of metformin treatment in hyperglycaemic patients affected by ischaemia with no obstructive coronary artery.Cardiovasc Res2025https://conductscience.org/library/papers/39786492PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AP2B1163PubTator's text mininghttps://conductscience.org/library/genes/163NCBI Gene
REN5972PubTator's text mininghttps://conductscience.org/library/genes/5972NCBI Gene
SLC5A26524PubTator's text mininghttps://conductscience.org/library/genes/6524NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
METFORMINCHEMBL1431Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1431

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36747244

GET https://conductscience.org/api/papers/v1/36747244/references?page=2